Dimorphic cardiac adaptation to obesity and arterial hypertension

Insights

Obesity causes heart enlargement and increased workload, while hypertension leads to heart muscle thickening. Combined, these conditions significantly elevate the risk of heart failure.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology
  • Medical Research

Background:

  • Obesity and hypertension are prevalent risk factors for cardiovascular disease.
  • Understanding their individual and combined effects on cardiac structure and function is crucial for clinical management.

Purpose of the Study:

  • To investigate the distinct and combined impacts of obesity and hypertension on cardiovascular structure and hemodynamics.
  • To differentiate the cardiac adaptations to obesity versus essential hypertension.

Main Methods:

  • Utilized M-mode echocardiography to assess cardiac dimensions and wall thickness.
  • Employed systemic hemodynamic measurements to evaluate cardiac function.
  • Compared paired groups of lean/obese and normotensive/hypertensive patients.

Main Results:

  • Obese patients exhibited significantly larger cardiac chambers (atrial, ventricular, aortic root) and increased ventricular mass, cardiac output, and stroke volume compared to lean individuals.
  • Hypertensive patients showed increased posterior wall thickness and a lower radius-to-wall thickness ratio, indicative of concentric hypertrophy.
  • Obesity induced eccentric hypertrophy (dilatation and hypertrophy), while hypertension caused concentric hypertrophy, irrespective of arterial pressure levels.

Conclusions:

  • Cardiac adaptation to obesity involves left ventricular dilatation and hypertrophy (eccentric hypertrophy).
  • Essential hypertension primarily results in concentric hypertrophy.
  • The coexistence of obesity and hypertension exacerbates cardiac workload and increases the long-term risk of congestive heart failure due to distinct hemodynamic mechanisms.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cellular Adaptation I: Introduction and Atrophy01:23

Cellular Adaptation I: Introduction and Atrophy

Cells can adapt to environmental changes to maintain function and avoid injury, a process called cellular adaptation. Adapted cells exist in a reversible intermediate state with changes in size, number, phenotype, metabolism, or function. These responses help cells meet altered physiological or pathological demands; for example, enlargement of breast and uterine tissues during pregnancy. Early adaptations may enhance function, but persistent stress eventually causes tissue damage.Types of...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...